🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Janice M. Mehnert

Eastern Cooperative Oncology Group

ORCID: 0000-0002-1043-3008

Also affiliated with NYU Langone Health, New York University

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “Pembrolizumab for the treatment of programmed death–ligand 1‒positive advanced carcinoid or pancreatic neuroendocrine tumors: Results from the KEYNOTE‐028 study”.

Pembrolizumab for the treatment of programmed death–ligand 1‒positive advanced carcinoid or pancreatic neuroendocrine tumors: Results from the KEYNOTE‐028 study

Cancer(2020)10.1002/cncr.32883
N/A
4.9DataRank · unranked
150 citations

Emily Bergsland, Bert H. O’Neil, Armando Santoro, Jan H.M. Schellens, Roger B. Cohen +15 more

Melanoma central nervous system metastases: An update to approaches, challenges, and opportunities

Pigment Cell & Melanoma Research(2022)10.1111/pcmr.13059
N/A
0.425DataRank · unranked
16 citations

Maya Dimitrova, Kevin Kleffman, Christopher Alvarez‐Breckenridge, Michael B. Atkins, Adrienne Boire +22 more

Risk and tropism of central nervous system (CNS) metastases in patients with stage II and III cutaneous melanoma

Cancer(2022)10.1002/cncr.34435
N/A
0.314DataRank · unranked
4 citations

Morgan Simons, Yingzhi Qian, Nadine Azmy, Janice M. Mehnert, Jeffrey S. Weber +3 more

Randomized phase II trial of dabrafenib and trametinib with or without navitoclax in patients (pts) with BRAF-mutant (MT) metastatic melanoma (MM) (CTEP P9466).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.9511
N/A
0.239DataRank · unranked
3 citations

Janice M. Mehnert, Anita Giobbie‐Hurder, Kari Kendra, Gino K. In, April K.S. Salama +14 more

Genomic and Transcriptomic Analyses of NF1-Mutant Melanoma Identify Potential Targeted Approach for Treatment

Journal of Investigative Dermatology(2022)10.1016/j.jid.2022.07.022
N/A
0DataRank · unranked
13 citations

Irineu Illa-Bochaca, Milad Ibrahim, Douglas M. Donnelly, Kelsey Zhu, Eleazar Vega‐Saenz de Miera +9 more

The risk and tropism of central nervous system metastases (CNS) in patients with stage II cutaneous melanoma.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.9551
N/A
0DataRank · unranked
0 citations

Min Jae Kim, Melissa Call, Nicholas Gulati, Judy Zhong, Janice M. Mehnert +2 more

Data from Riluzole Enhances Ionizing Radiation–Induced Cytotoxicity in Human Melanoma Cells that Ectopically Express Metabotropic Glutamate Receptor 1 In Vitro and In Vivo

(2023)10.1158/1078-0432.c.6519486
N/A
0DataRank · unranked
0 citations

B. Wall, Stuti Ahlawat, Camille Green, Devora Schiff, Janice M. Mehnert +4 more

Data from Baseline Serum Autoantibody Signatures Predict Recurrence and Toxicity in Melanoma Patients Receiving Adjuvant Immune Checkpoint Blockade

(2023)10.1158/1078-0432.c.6532566
N/A
0DataRank · unranked
0 citations

Wenke Liu, David Fenyö, Megan Wind‐Rotolo, Michelle Krogsgaard, Janice M. Mehnert +4 more

Data from Riluzole Enhances Ionizing Radiation–Induced Cytotoxicity in Human Melanoma Cells that Ectopically Express Metabotropic Glutamate Receptor 1 In Vitro and In Vivo

(2023)10.1158/1078-0432.c.6519486.v1
N/A
0DataRank · unranked
0 citations

B. Wall, Stuti Ahlawat, Camille Green, Devora Schiff, Janice M. Mehnert +4 more

Data from Baseline Serum Autoantibody Signatures Predict Recurrence and Toxicity in Melanoma Patients Receiving Adjuvant Immune Checkpoint Blockade

(2023)10.1158/1078-0432.c.6532566.v1
N/A
0DataRank · unranked
0 citations

Wenke Liu, David Fenyö, Megan Wind‐Rotolo, Michelle Krogsgaard, Janice M. Mehnert +4 more